References for the access to treatment section and thanks

References

This information has been compiled using information from a number of reliable sources, including:

• All Wales Medicines Strategy Group. Towards Improving the Availability of Medicines for patients in Wales – Expert Group Review. January 2009.
• Aneurin Bevan Health Board website. www.wales.nhs.uk/sitesplus/866/page/56366 (accessed February 2012).
• Arrangements for NHS patients receiving healthcare services through private healthcare arrangements. 2009. The Scottish Government.
• CMO letter. Circular HSC (SQSD) 04/11 NICE Technology Appraisals and New Clinical Guidelines – New Process for Endorsement, Implementation, Monitoring and Assurance in Northern Ireland. 26 September 2011. Department of Health, Social Services and Public Safety.
• CMO letter. Guidance to further strengthen the safe and effective use of new medicines across the NHS in Scotland. 2012. The Scottish Government.
• CMO letter. Implementing CEL 17 (2010): Introduction and availability of newly licensed medicines in the NHS in Scotland – Good Practice Guidance for NHS Board Management of Individual Patient Treatment Requests (IPTRs). 2011. The Scottish Government.
• Guidance on NHS patients who wish to pay for additional private care. 2009. Department of Health.
• Healthcare Policy and Strategy Directorate. Introduction and availability of newly licensed medicines in the NHS in Scotland. 2010. The Scottish Goverment.
• National Assembly for Wales. Medicines Funding in the NHS. October 2011.
• National Institute for Health and Clinical Excellence. www.nice.org.uk/guidance/ta/index.jsp (accessed September 2012). Overview of the Licensing Process as it Applies to Medicinal Products in the UK. 2003. United Kingdom National Medicines Information.
• Scottish Medicines Consortium website. www.scottishmedicines.org. (accessed February 2012).

Thanks

Thanks to Professor Tim Eisen, Professor of Medical Oncology; Dr Bridget Gwynne and Dr David Linden, Macmillan GP Advisers; Kate Seymour, Macmillan External Affairs Manager; and all of the people affected by cancer who reviewed this edition.

Reviewing information is just one of the ways you could help when you join our Cancer Voices network|.